Welcome to Mesothelioma.net - Turning Hope and Faith into Action.

Archive for October 2014

Verastem Presents Findings at International Conference

Attendees at the 12 International Mesothelioma Interest Group Conference, being held at the Cape Town International Conference Centre in Cape Town, South Africa, heard encouraging news from representatives of Verastem, Inc. regarding some of their clinical and preclinical trial results. Verastem is a drug manufacturer that specifically focuses on the discovery and development of drugs…

Read More

Blood Pressure Drug Shows Promise For Mesothelioma Treatment

A popular blood pressure medication that has been used in the treatment of a variety of other conditions is now showing promise in the treatment of malignant pleural mesothelioma. Researchers in Japan have indicated that they have been studying the impact of naftopidil for several years and have high hopes for its future. Naftopidil is…

Read More

Researchers Boost Chemotherapy Impact for Mesothelioma Patients

Researchers Boost Chemotherapy Impact for Mesothelioma Patients A team of scientists working to find a way to make malignant mesothelioma tumor cells more sensitive to chemotherapy believe that they have found a way, and the answer lies in a specific estrogen receptor. The researchers hail from two different universities in Europe. A group of pharmaceutical…

Read More

New Study Questions Benefits of Radiation Therapy

The results of a new study have been released at the European Society for Medical Oncology (ESMO) Congress 2014, held in Madrid, and they reveal that high-dose radiotherapy adds no significant survival benefit following radical surgery and chemotherapy treatments. The results represent a disappointment to researchers, physicians and patients alike. According to current ESMO president…

Read More